Group Leader Single-Cell Genomics Unit
Dr. Michael Sterr
“By using single-cell genomics, we can increase our understanding of the developmental programs that govern the formation of pancreatic and intestinal endocrine cells to improve diabetes therapy.”
Research focus and Academic Career
Michael Sterr studied Bioengineering and Biology in Munich.
In 2013, he joined the Lab of Heiko Lickert for his PhD, where he studied the epigenetics of the endocrine cell fate decision in both pancreas and intestine.
During his postdoc time, he focused on single-cell genomics techniques and data analysis to dissect the dynamics of endocrine differentiation.
Since 2021, he leads the Single-Cell Genomics Group at the Institute of Diabetes and Regeneration Research.
Single-cell-based methods are key technologies to uncover the cellular complexity of biological systems, and allow the characterization of different cell types and cellular states, as well as the reconstruction of developmental trajectories. Leveraging single-cell transcriptomic and epigenomic analyses, Michael aims to provide insight into the molecular mechanisms guiding the endocrine lineage decision and the specification of different endocrine cell types.
Professional Career
Head of the group Single Cell Analysis
Helmholtz Munich, Institute of Diabetes and Regeneration Research, Neuherberg, Germany
Postdoc
Helmholtz Munich, Institute of Diabetes and Regeneration Research, Neuherberg, Germany
PhD Student
Helmholtz Munich, Institute of Diabetes and Regeneration Research, Prof. Dr. Heiko Lickert. Project: “Transcriptional Regulation of Endocrine Cell Formation and Function in Pancreas and Intestine”
